Skip to main content
. 2018 Jan 22;9(2):73. doi: 10.1038/s41419-017-0109-1

Fig. 6. Deletion of caveolin-binding sites in N-terminal domain results in Fas-ligand mislocalization and cell-death suppression.

Fig. 6

a Lysates of non-induced (left upper panel), tetracycline-induced for 4 h HeLa-pcDNA4/TO-FasL cells (right upper panel), HeLa cells transfected with mutant forms of FasL-Δ21 (left lower panel), and form I (right lower panel) were separated by ultracentrifugation in a sucrose gradient. Distribution of raft-specific (flotillin-1, caveolin-1, GM1 ganglioside (GM)) and non-specific (transferrin receptor1 (TfR1)) markers as well as FasL was analyzed by immunoblotting. b Expression levels of FasL and its mutant forms in the specified time periods were estimated by immunoblot analysis with anti-FasL Abs. Survival of HeLa cells overexpressing wild-type and mutant forms (FasL-Δ21 and form I) of FasL, incubated with tetracycline for the times indicated (chart). Cell viability was determined by the neutral-red uptake assay. Results are presented as mean ± s.e.m. of four experiments (each in triplicate)